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tc), hospitalyzed between september 08 and septem-
er 09 in a Hospital of Infectious Diseses from Eastern
omania. Double disc synergy test using cefotaxime and
moxicillin/clavulanic acid discs was used to screen ESBL
roducers and these strains were subsequently subjected to
onﬁrmatory Etest.
Results: E. coli resistance to cefotaxime, ceftazidime,
efoxitin, ciproﬂoxacin and imipenem was found to be 40,
9, 6, 30 and 1% respectively. Klebsiella resistance to cefo-
axime, ceftazidime, cefoxitin, ciproﬂoxacin and imipenem
as 70, 57, 22, 41 and 4% respectively. % of ESBL produc-
rs E. coli was 15% (97 strains) and Klebsiella was 38% (35).
ll the ESBL producing strains were susceptible in 100% to
mipenem and meropenem.
Conclusion: Carbapenems remain the most active agents
gainst Gram-negative isolates, including ESBL producers
train of E. coli and Klebsiella spp. isolated from community-
cquired and nosocomial infections from Eastern Romania.
oi:10.1016/j.ijid.2010.02.1575
3.020
an we rely on automated VITEK2 system the detection
f KPC and other class A carbapenemase producers enter-
bacteriaceae?
. Pasteran ∗, C. lucero, R. soloaga, A. Corso
Instituto Nacional de Enfermedades Infecciosas ‘‘Dr. C. Mal-
rán’’, Buenos Aires, Argentina
Background: Class A carbapenemases have become more
revalent within Enterobacteriaceae. Proﬁcient methods
re needed for their early detection in clinical micro-
iology laboratories in any attempt aimed for targeting
ptimal antimicrobial therapy and controlling their spread.
utomated systems, as VITEK2, are increasingly used for
outine susceptibility testing to decrease the in-laboratory
urnaround time. However, the performance of VITEK2 for
he whole class A carbapenemase family detection has never
een assessed before. Objective: to determine the perfor-
ance of VITEK2 for carbapenemase detection compared
ith both, CLSI agar dilution MIC and the genotype obtained
y molecular methods.
Methods: Methods: we designed a panel composed by
iverse bacterial genera with distinct carbapenem suscep-
ibility patterns composed by 37 carbapenemase producers
nd 34 nonproducers (n): KPCs (17) Sme (10), NMC-A/IMI
2), GES (4), VIM/IMP (4) and CTX-M (12), AmpCs (12),
ombined mechanisms and others (10), respectively. The
esistance mechanisms of the strains were assessed by
CR/DNA sequencing. Each isolate was tested with the
ITEK2 using the AST-N082 cards speciﬁcally designed for
outh American countries (which included only imipenem
IPM- and meropenem -MEM-), according to the manufac-
urer’s instructions and by CLSI agar dilution MICs for both
arbapenems. Discrepant results were resolved by retesting
he isolates.
Results: Overall categorical interpretations with VITEK2
howed a 72% and 79% of agreement with reference MICs
or IPM and MEM, respectively. Very major (VM), major (MA)
nd minor (MI) errors were: IPM, VM 3%, MA 11% and MI 13%;
EM, VM 4%, MA 6% and MI 11%. Most of the errors (>80%)
g
(
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ccurred among carbapenemase producers. The expert sys-
em showed sensitivity (SN) of 76% and speciﬁcity (SP) of 87%
or carbapenemase detection, when confronted to the geno-
ype, with the greatest SN for KPCs (82%) and the lower for
BLs (25%). The recognition of suspected carbapenemase
roducers could be increased with the combined used of
PM and MEM with modiﬁed cut-off points of >=2.0mg/L and
=1.0mg/L, respectively (SN 97%, SP 90%).
Conclusion: VITEK2 may be suitable in clinical labora-
ories for Class A carbapenemase detection, but should
e accompanied with modiﬁcations in the cut-off used for
creening of suspected carbapenemase producers to ensure
heir proper detection.
oi:10.1016/j.ijid.2010.02.1576
3.021
mergence of multidrugresistant gram negative bacilli
nd enterococci from rectal swabs of newborn and their
others from Central India
. Chitnis1, V. Chitnis2,∗, D. Chitnis1
Choithram Hospital and research center, Indore, India
Medical University of Americas, St James Parish, Saint
itts and Nevis
Background: Newborn babies acquire gut ﬂora mainly
rom mother and surrounding. We had observed in the faecal
amples of newborns prevalence, colonization of multidrug
esistant, ESBL pandrug resistant gram negative bacteria,
ancomycin resistant enterococci as a new threat in the
ewborn admitted in hospital.The inﬂux of these bacteria
nto hospitals has major implications for infection—control
nd empirical treatment strategies.
Methods: A total of 140 samples of faeces from neonates
nd mothers admitted in general maternity ward and ICU
f two hospital in central India were examined within
4-48 hours for presence of ESBL, pandrug resistant gram
egative bacilli, and vancomycin resistant
enterococci. Antibiotic susceptibility test were per-
ormed using Kirby-Bauer disc diffusion method and results
ere interpreted according to CLSI. Van A and ESBL gene
as conﬁrmed using E test, PCR and RT PCR.
Results: 1. A total of 48 E.coli, 49 Klebsiella, 21 Pseu-
omonas and 52 Entercocci isolates were obtained. The
ercentage of multidrug resistant E.coli, Klebsiella, Pseu-
omonas and enterococci was 78.79, 66.67, 58.8 and 91.18%
espectively. For gram negative bacilli % resistance for chlo-
amphenicol (47%), cabapenem 58.9% and ampicillin (74.3%)
minoglycosides (70.9%), quinolones (65.8%) and cefopara-
one+ sulbactum (58.1%). piperacillin+tazobactum (69.2%)
otrimoxazole (47%) cephalosporin (71.1%).The prevalence
f ESBL gene (TEM and SHV) among E.coli and Klebsiella
as 100% and 75% respectively. The pandrug resistant was
8.15% among E.coli and 20.4% among Klebsiella and 1.5%
mong Pseudomonas Of 52 enterococci, 47.06%. of them
ere vancomycin resistant strain and harboured van A gene.
nterococci were showing a high level resistance to amino-
lycosides (82.35%), ampicillin (82.35%), chloramphenicol
38.24%), teicoplanin (44.12%) and linezolid (8.82%).
Conclusion: We report high rates of colonization with
SBL and pandrug resistant gram negative organism and
trac
c
ﬁ
d
2
M
a
F
t
S
Y
1
2
U
3
c
U
P
c
l
a
a
c
s
s
o
c
c
p
v
p
t
T
(
(
s
s
t
p
q
c
s
M
t
s
q
(
o
w
w
t
c14th International Congress on Infectious Diseases (ICID) Abs
vancomycin resistant enterococci among faecal samples
from newborn admitted in ICU, maternity ward with in 24-
48 hours from two hospitals in central India. The colonization
is mainly due to antibiotic usage by the mother as well as
newborn in ICU. Antibiotics used were cefotaxime, gentam-
icin amikacin and ciproﬂoxacin. It poses a great threat to
infection control measures and complicates the selection of
empirical treatment.
doi:10.1016/j.ijid.2010.02.1577
23.022
Patients with hematological malignancies who are pre-
scribed quinolone prophylaxis postchemotherapy in a
hospital with high gram-negative quinolone resistance are
at a higher risk for febrile neutropenia
E. Ng1, Y.X. Liew2, Y. Ding1, L.P. Koh1, J. Jin1, L.Y. Hsu1,∗
1 National University Health System, Singapore, Singapore
2 Singapore General Hospital, Singapore, Singapore
Background: Febrile neutropenia (FN) remains a major
cause of morbidity and mortality in patients receiving
chemotherapy. Major prophylactic strategies include gran-
ulocyte colony stimulating factor and antibiotics, the most
widely used of which are quinolones. While quinolone pro-
phylaxis has been shown to be effective in areas where
ﬂuoroquinolone resistance is low, this same efﬁcacy has
not been proven in areas where resistance is high. We
reviewed the efﬁcacy of quinolone prophylaxis in prevent-
ing FN in patients with leukemia and lymphoma undergoing
chemotherapy at our institute - a tertiary academic medical
center where quinolone resistance among aerobic gram-
negative bacilli (GNB) exceed 40%.
Methods: A retrospective chart review was performed on
all patients with acute leukemia and lymphoma who under-
went chemotherapy and were at high risk (>5%) of FN at our
institute between 1 October 2008 and 30 September 2009.
Demographic and clinical characteristics for each episode of
chemotherapy were collected, with the main outcome being
presence/absence of FN. Generalized estimating equation
(GEE) models were used to analyze the data to adjust for
serial autocorrelation due to repeat measurements of both
outcome and covariates for each patient.
Results: There were a total of 510 chemotherapy
episodes from 119 patients within the study period, with
median number of chemotherapy episodes being 3. Demo-
graphic and clinical characteristics - including disease stage
- were similar between patients on and off quinolone
prophylaxis. Among all patients, those on quinolone prophy-
laxis were at signiﬁcantly higher risk for both FN (OR:5.4;
95%CI:3.1-9.4; p < 0.01) and FN with bacteremia (OR:5.3;
95%CI:2.7-10.6; p < 0.01). Subgroup analysis for patients
with acute myeloid leukemia and lymphoma showed simi-
lar higher risk of FN for patients with quinolone prophylaxis
(OR:7.1; 95%CI:2.2-23.0; p < 0.01 and OR:3.8; 95%CI:1.7-8.7;
p < 0.01 respectively). All GNB isolated in these patients
were resistant to quinolones.Conclusion: In a hospital with high quinolone resis-
tance rates, quinolone prophylaxis failed to protect patients
with hematological malignancies from developing FN as
well as FN associated with bacteremia. A prospective
t
e
uts e41
ase-control study should be conducted to validate these
ndings.
oi:10.1016/j.ijid.2010.02.1578
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ultidrug resistant and sensitive strains of Pseudomonas
eruginosa: Establishing clonal relationship by Pulsed
ield Gel Electrophoresis and in vitro antibiotic synergy
esting by E test
.F.A. Mohd Nawi1,∗, R. Karunakaran2, K.-L. Thong3, M.Y.
usof2, J. Vadivelu2
Universiti Teknologi MARA, Shah Alam, Selangor, Malaysia
Department of Medical Microbiology, Faculty of Medicine,
niversity of Malaya, Kuala Lumpur, Malaysia
Institute of Biological Sciences, Laboratory of Biomedi-
al Science and Molecular Microbiology, Faculty of Science,
niversity of Malaya, Kuala Lumpur, Malaysia
Background: The emergence of multidrug resistant
seudomonas aeruginosa (MDRPA) as one of the leading noso-
omial pathogens imposes a serious health threat due to
imited antibiotic options. In this study, a sample of clon-
lly distinct MDRPA and sensitive strains of Pseudomonas
eruginosa (SSPA) were tested against various antibiotics
ombinations to establish synergistic activity against these
trains.
Methods: A total of 39 retrospectively collected MDRPA
trains isolated over three years with a particular antibi-
gram (sensitive to colistin but resistant to ceftazidime,
efepime, cefoperazone, cefoperazone/sulbactam,
iproﬂoxacin, imipenem, meropenem, piperacillin,
iperacillin-tazobactam, gentamicin, netilmicin, with
arying susceptibility to amikacin) and 19 SSPA collected
rospectively were genotyped using Spe1 DNA macrorestric-
ion analysis and pulsed-ﬁeld gel electrophoresis (PFGE).
he strains were from different patients from various sites
blood, tissue, ﬂuid, catheter tip, bronchiol alveolar lavage
BAL), urine, sputum, swab, tracheal secretion and nasal
wab). Clonal relatedness was determined at ≥85% level of
imilarity and grouped into different clusters. A representa-
ive strain from each cluster was tested against 10 different
aired combinations of various antimicrobials (-lactams,
uinolone, aminoglycoside, tigecycline, rifampicin and
olistin) to establish synergistic activity against these
trains using the investigational E test ﬁxed ratio method.
Results: There were 46 distinct clones out of a total of 58
DRPA and SSPA resolved by PFGE from which 10 clonally dis-
inct strains (8 MDRPA and 2 SSPA strains) were selected for
ynergy testing. The antibiotic combination which most fre-
uently demonstrated synergy was cefepime with amikacin
4/10 strains). Other synergistic combinations were aztre-
nam with either ceftazidime or cefepime, and meropenem
ith ciproﬂoxacin (3/10 strains respectively), ceftazidime
ith either ciproﬂoxacin or amikacin (2/10 strains respec-
ively) and imipenem with ciproﬂoxacin (1/10 strains). The
ombination of ceftazidime with amikacin was antagonis-
ic in 1/10 strains. The other antibiotics combinations were
ither additive or indifferent.
Conclusion: PFGE was a useful and discriminative molec-
lar subtyping tool to establish clonal relatedness among
